ABBOTT LABORATORIES (ABT) Stock Price, Forecast & Analysis
USA - NYSE:ABT - US0028241000 - Common Stock
ABT Key Statistics, Chart & Performance
The current stock price of ABT is 125.8 USD. In the past month the price decreased by -5.43%. In the past year, price increased by 7.9%.
ABT Latest News, Press Relases and Analysis
ABT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 62.58 | 193.16B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.51 | 146.46B | ||
| SYK | STRYKER CORP | 27.53 | 138.63B | ||
| MDT | MEDTRONIC PLC | 16.35 | 115.98B | ||
| IDXX | IDEXX LABORATORIES INC | 57.27 | 57.77B | ||
| BDX | BECTON DICKINSON AND CO | 12.55 | 51.32B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.74 | 49.40B | ||
| RMD | RESMED INC | 24.89 | 35.96B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.19 | 33.92B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.88 | 26.98B | ||
| DXCM | DEXCOM INC | 32.89 | 23.99B | ||
| STE | STERIS PLC | 25.35 | 23.82B |
Related stock screener links
About ABT
Company Profile
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 114,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
Company Info
ABBOTT LABORATORIES
100 Abbott Park Road, Abbot Park
ABBOTT PARK ILLINOIS 60064 US
CEO: Robert B. Ford
Employees: 114000
Phone: 12246676100
ABBOTT LABORATORIES / ABT FAQ
What does ABT do?
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 114,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
Can you provide the latest stock price for ABBOTT LABORATORIES?
The current stock price of ABT is 125.8 USD. The price increased by 1.58% in the last trading session.
Does ABT stock pay dividends?
ABBOTT LABORATORIES (ABT) has a dividend yield of 1.89%. The yearly dividend amount is currently 2.21.
How is the ChartMill rating for ABBOTT LABORATORIES?
ABT has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
Is ABBOTT LABORATORIES (ABT) expected to grow?
The Revenue of ABBOTT LABORATORIES (ABT) is expected to grow by 6.43% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the market capitalization of ABT stock?
ABBOTT LABORATORIES (ABT) has a market capitalization of 218.95B USD. This makes ABT a Mega Cap stock.
What is the outstanding short interest for ABBOTT LABORATORIES?
The outstanding short interest for ABBOTT LABORATORIES (ABT) is 1.12% of its float.
ABT Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ABT. When comparing the yearly performance of all stocks, ABT turns out to be only a medium performer in the overall market: it outperformed 48.21% of all stocks.
ABT Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to ABT. Both the health and profitability get an excellent rating, making ABT a very profitable company, without any liquidiy or solvency issues.
ABT Financial Highlights
Over the last trailing twelve months ABT reported a non-GAAP Earnings per Share(EPS) of 4.99. The EPS increased by 10.4% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 32.43% | ||
| ROA | 16.64% | ||
| ROE | 27.65% | ||
| Debt/Equity | 0.26 |
ABT Forecast & Estimates
35 analysts have analysed ABT and the average price target is 146.85 USD. This implies a price increase of 16.74% is expected in the next year compared to the current price of 125.8.
For the next year, analysts expect an EPS growth of 11.44% and a revenue growth 6.43% for ABT